Skip to content Skip to footer

Who should be tested for BAP1 mutations?

Currently no clinical criteria have been established for the diagnosis of BAP1-TPDS. However the syndrome should be suspected and testing offered to individuals who have one of the following:

  • ≥2 confirmed BAP1-TPDS associated tumors*

 OR

  • One BAP1-TPDS tumor and a 1st- or 2nd-degree relative with a confirmed BAP1-TPDS tumor*
    * excluding two cutaneous melanomas given their high frequency in the general population

Confirmed BAP1-TPDS tumors include the following

  • BAP1-inactivated melanocytic tumors
  • Uveal (eye) melanoma
  • Malignant mesothelioma
  • Cutaneous (skin) melanoma
  • Clear cell renal cell (kidney) carcinoma